XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Series F Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 6 $ 140,521 $ 176,033,817 $ 106,303 $ (165,583,091) $ 10,697,556
Balance, shares at Dec. 31, 2023 6,075 140,520,163        
Issuance of Preferred Stock, Series F Convertible, net of issuance cost $ 1 949,999 950,000
Issuance of Preferred Stock, Series F Convertible, net of issuance cost, shares 1,000          
Conversion of Preferred Stock, Series F Convertible shares to Common Stock $ (3) $ 59 (56)
Conversion of Preferred Stock, Series F Convertible shares to Common Stock, shares (3,130) 59,041        
Dividends on Series F Preferred Stock (61,235) (61,235)
Stock-based compensation expense 18,580 18,580
Conversion of Convertible Note principal to Common Stock $ 2 99,998 100,000
Conversion of Convertible Note principal to Common Stock, shares   1,597        
Foreign currency cumulative translation adjustment (163,653) (163,653)
Net income (loss) (6,315,587) (6,315,587)
Effect on existing shares due to Reverse Split on February 9, 2024 $ (133,495) 133,495
Effect on existing shares due to Reverse Split on February 9, 2024, shares   (133,493,864)        
Effect on existing shares due to Reverse Split on October 14, 2024 $ (6,886) 6,886
Effect on existing shares due to Reverse Split on October 14, 2024, shares   (6,885,773)        
Exercise of warrants issued with Series F $ 17 497,684 $ 497,701
Exercise of warrants issued with Series F, shares   16,590      
Issuance of Restricted Common Stock
Issuance of Restricted Common Stock, shares   75        
Conversion Price of Promissory Note on Exchange Agreement 3,488,851 3,488,851
Deemed dividend on Series F Preferred Stock 5,249,704 (5,249,704)
Issuance costs for sale of Preferred Stock (159,293) (159,293)
Balance at Mar. 31, 2024 $ 4 $ 218 186,258,430 (57,350) (177,148,382) 9,052,920
Balance, shares at Mar. 31, 2024 3,945 217,829        
Balance at Dec. 31, 2024 $ 6 $ 9,662 212,715,967 (86,376) (218,381,218) (5,741,959)
Balance, shares at Dec. 31, 2024 5,935 9,661,664        
Issuance of Preferred Stock, Series F Convertible, net of issuance cost $ 1 1,499,999 1,500,000
Issuance of Preferred Stock, Series F Convertible, net of issuance cost, shares 1,500          
Conversion of Preferred Stock, Series F Convertible shares to Common Stock $ (2) $ 2,191 (2,189)
Conversion of Preferred Stock, Series F Convertible shares to Common Stock, shares (2,410) 2,190,908        
Dividends on Series F Preferred Stock (67,651) (67,651)
Exercise of Series B Warrants 268 520,565 520,833
Exercise of Series B Warrants, shares   267,849        
Stock-based compensation expense 49,880 49,880
Conversion of Convertible Note principal to Common Stock $ 700 769,300 770,000
Conversion of Convertible Note principal to Common Stock, shares   700,000        
Deemed dividend on Series F Preferred Stock and Warrants 1,056,332 (1,056,332)
Amortization of unrecognized periodic pension costs   107,565 107,565
Foreign currency cumulative translation adjustment (21,779) (21,779)
Net income (loss) 7,060,039 $ 7,060,039
Exercise of warrants issued with Series F, shares          
Balance at Mar. 31, 2025 $ 5 $ 12,821 $ 216,542,203 $ (590) $ (212,377,511) $ 4,176,928
Balance, shares at Mar. 31, 2025 5,025 12,820,421